Systemic Lupus Erythematosus Responder Index Assessment of Responders in EMBLEM, a Phase IIb Study in Patients with Moderate to Severe Systemic Lupus Erythematosus

被引：0
|
作者：
Petri, Michelle [1 ]
Pike, Marilyn C. [2 ]
Kelley, Lexy [3 ]
Kilgallen, Brian [4 ]
Gordon, Caroline [5 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Med Pharm Consulting Inc, Cambridge, MA USA
[3] UCB, Smyrna, GA USA
[4] UCB, Brussels, Belgium
[5] Univ Birmingham Sch Med, Birmingham B15 2TT, W Midlands, England
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1378
引用
下载
收藏
页码：S539 / S539
页数：1
相关论文
共 50 条
  • [1] Performance of the Systemic Lupus Erythematosus Responder Index in Juvenile Systemic Lupus Erythematosus
    Mina, Rina
    Klein-Gitelman, Marisa
    Nelson, Shannen L.
    Eberhard, B. Anne
    Higgins, Gloria C.
    Singer, Nora G.
    Levy, Deborah M.
    Onel, Karen
    Olson, Judyann C.
    Pendl, Joshua D.
    Baker, Aimee
    Imundo, Lisa F.
    Tucker, Lori B.
    Schanberg, Laura E.
    Punaro, Marilynn G.
    O'Neil, Kathleen M.
    Ruperto, Nicolino
    Lovell, Daniel J.
    Brunner, Hermine
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S783 - S784
  • [2] Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus
    Leosuthamas, Pornsawan
    Narongroeknawin, Pongthorn
    Chaiamnuay, Sumapa
    Asavatanabodee, Paijit
    Pakchotanon, Rattapol
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (04) : 667 - 672
  • [3] Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus
    Mina, Rina
    Klein-Gitelman, Marisa S.
    Nelson, Shannen
    Eberhard, B. Anne
    Higgins, Gloria
    Singer, Nora G.
    Onel, Karen
    Tucker, Lori
    O'Neil, Kathleen M.
    Punaro, Marilynn
    Levy, Deborah M.
    Haines, Kathleen
    Martini, Alberto
    Ruperto, Nicolino
    Lovell, Daniel
    Brunner, Hermine I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (02) : 401 - 406
  • [4] EPRATUZUMAB DEMONSTRATES CLINICALLY MEANINGFUL IMPROVEMENTS IN PATIENTS WITH MODERATE-TO-SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM EMBLEM™, A PHASE IIB STUDY
    Gordon, Caroline
    Kalunian, K.
    Petri, M.
    Strand, V.
    Kilgallen, B.
    Barry, A.
    Wallace, D.
    RHEUMATOLOGY, 2012, 51 : 25 - 25
  • [5] Moderate and severe neutropenia in patients with systemic lupus erythematosus
    Martinez-Banos, D.
    Crispin, J. C.
    Lazo-Langner, A.
    Sanchez-Guerrero, J.
    RHEUMATOLOGY, 2006, 45 (08) : 994 - 998
  • [6] Moderate to Severe Depression in Patients with Systemic Lupus Erythematosus
    Chalhoub, Nathalie
    Luggen, Michael
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [7] Clinical and Laboratory Correlates in Responders (by the Systemic Lupus Erythematosus Responder Index) in Phase 3 Belimumab Clinical Trials
    Furie, R. A.
    Zhong, Z. J.
    Freimuth, W.
    Petri, M.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S534 - S535
  • [8] Severe pneumonia in patients with systemic lupus erythematosus
    Garcia-Canas, Iveth Eunice
    Cuevas-Orta, Enrique
    Abud-Mendoza, Carlos
    LUPUS, 2020, 29 (11) : 1483 - 1484
  • [9] Assessment of systemic lupus erythematosus
    Lam, GKW
    Petri, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (05) : S120 - S132
  • [10] Systemic Lupus Erythematosus (SLE) Responder Index [SRI(4)] Response Is Associated with Global Benefit in Patients with Moderate to Severe SLE
    Furie, R.
    Wang, L.
    Drappa, J.
    Illei, G.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345